Site Reference ID/Investigator# 43574 — Seattle, Washington

Site Reference ID/Investigator# 43574 is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 43574 has participated in 1 clinical trials.

Therapeutic areas: Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1.

Sponsors: AbbVie (prior sponsor, Abbott).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 43574?

Site Reference ID/Investigator# 43574 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 43574 conducted?

Site Reference ID/Investigator# 43574 has 1 clinical trials on record. Their work covers Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1.

Is Site Reference ID/Investigator# 43574 accredited by Crixeo Health?

Site Reference ID/Investigator# 43574 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 43574?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.